These findings support further investigation of HNF4A-related lipid pathways and require replication in independent Chinese and multi-ancestry cohorts before genetic and lipid profiles can be considered for T2D risk stratification.
Abstract
Background/Objectives: To evaluate the association between HNF4A rs4812829 and type 2 diabetes (T2D) in a rural Chinese population and to investigate its interaction with blood lipids in the association. Methods: A total of 4496 participants free of diabetes at baseline from a family-based cohort in rural China were included. Demographic, lifestyle, and medical history data were collected via standardized questionnaires. Anthropometric and biochemical measurements were performed using standardized protocols and automated assays on fasting blood samples. Mixed-effects Cox proportional hazards models, accounting for familial clustering, were employed to examine the association between HNF4A rs4812829 and incident T2D risk. Additionally, multiplicative interaction terms were used to assess interactions. Results: After a median follow-up of 10.76 years, 895 incident T2D cases were identified. Under an additive genetic model, each additional G allele of rs4812829 was significantly associated with an increased risk of T2D (HR 1.38, 95% CI 1.19–1.59). A significant multiplicative interaction was observed between rs4812829 and HDL-C (p = 0.004). In genotype-stratified analyses, higher HDL-C levels were strongly associated with lower T2D risk among AA homozygotes (HR 0.04, 95% CI 0.003–0.43) and AG heterozygotes (HR 0.30, 95% CI 0.10–0.84), but not among GG homozygotes (HR 1.32, 95% CI 0.35–4.91). Conclusions: This study finds HNF4A intronic variant rs4812829 is significantly associated with the incident T2D risk in a rural Chinese population, and this association exhibits an interaction with HDL-C levels. These findings support further investigation of HNF4A-related lipid pathways and require replication in independent Chinese and multi-ancestry cohorts before genetic and lipid profiles can be considered for T2D risk stratification.
BACKGROUND
Type 2 diabetes (T2D) affects 11.1% of the global population, underscoring the need for biomarkers that help characterize glycemic control status among treated individuals. We evaluated the association between the FTO variant rs9939609‑A and glycemic control in a Mexican population.
METHODS
A total of 174 individuals living with T2D from Mérida and Sisal, Yucatán, were included, of whom 85% were receiving oral hypoglycemic agents as main treatment. Glycemic control was defined cross‑sectionally as good (≤ 130 mg/dL, n = 63) or poor (> 130 mg/dL, n = 111) with fasting glucose. Linear mixed models incorporating relevant covariates and a family random intercept were used. Effect size estimates were transformed to logit odds ratios.
RESULTS
After adjustment for age, sex, BMI, years since T2D diagnosis, and treatment, the minor allele of rs9939609 (A) was associated with an increased risk of poorer glycemic control, reaching significance under both the additive (OR = 1.145 [1.003-1.307], p = 0.047) and recessive (OR = 1.514 [1.026-2.234], p = 0.038) models. In an alternative model adjusting for waist circumference instead of BMI, the effect of rs9939609‑A in the additive model was slightly attenuated (OR = 1.135 [0.994-1.297], p = 0.063), while the recessive model remained significant (OR = 1.486 [1.010-2.189], p = 0.046).
CONCLUSIONS
rs9939609-A was associated with poorer glycemic control in this exploratory cohort, but replication in larger and ancestrally characterized samples is required.
N. Fragoso-Bargas, R. V. Escarcega-Castro, I. Quintal-Ortiz et al.· BMC Research Notes· 0 citations
OLR1 rs11053646 SNP does not appear to be associated with T2D risk in Saudi adults, and small sample size may have limited statistical power to detect potential associations.
V. Vennu· Endocrine, Metabolic & Immun...· 0 citations
The polymorphism at the site (rs1800976) was greatly linked to higher forms of CAD and T2DM+CAD indicating that the site could serve as a genetic marker of cardiometabolic risk.
Vikas Kumari, Nisha Khola, Rajan Sharma et al.· International Journal of Dru...· 0 citations
The TCF7L2 rs12255372 polymorphism, particularly the T allele, is associated with an increased risk of type 2 diabetes mellitus and early renal dysfunction, and may serve as a promising molecular marker for early risk stratification of diabetic kidney disease.
Z.A. Raximberdiyeva· Journal of modern medicine· 0 citations
Multivariable analysis provides evidence supporting an independent association between the MIA3 rs17465637 variant and CAD susceptibility in this Saudi cohort, and the observed associations with adverse lipid profiles further provide evidence linking this specific locus to the molecular mechanisms underlying cardiovascular disease.
N. Bogari, Samar N. Ekram, Amr A. Amin et al.· Diagnostics· 0 citations
This study identified and temporally validated key metabolic and clinical markers associated with prevalent T2D in obese Indians using age- and sex-matched case-control analysis and demonstrated good discrimination in obese Indian individuals.
Anagha Vyawahare, Pramod Tripathi, Nidhi Kadam et al.· Frontiers in Clinical Diabet...· 0 citations